Clinical Trial Update: Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing rechallenge of a prior regimen in third or later-line chemotherapy for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Fudan University | Conditions: Metastatic Colorectal Cancer, Chemotherapy Effect | Phase 2 | Status: COMPLETED